1-Minute Healthcare News Today— June 13, 2023

Pfizer, a US pharmaceutical company, and GSK, a British pharmaceutical company, are expected to encounter stiff rivalry in the respiratory syncytial virus (RSV) vaccine market. Arexvy, a new vaccine developed by GSK and authorized by the US Food and Drug Administration, is the first RSV vaccine approved for use in the United States. Read here.?

A rabies-infected bat was discovered in Burlington, marking the first confirmed incidence of animal rabies in Halton this year, according to Halton Region Public Health (HRPH) officials. According to a statement released by HRPH on Monday, the bat was discovered in the southwest neighborhood of Aldershot and had "no known human contact." Read here.

Meanwhile, weight loss medications such as Ozempic, Mounjaro, and Wegovy are particularly successful. However, people may face long-term adverse effects in addition to weight loss. Read more here.

According to the global vaccination alliance Gavi, childhood immunization rates began to rebound last year in the world's poorest countries after being severely impacted by COVID-19 interruptions. According to data, 80% of kids received the DTP3 (diphtheria, tetanus, and pertussis) vaccine last year. In 2020 the figure was 78% and? 77% in 2021. Read here.

Lastly, after promising results from a late-stage trial, a vaccine for chikungunya—a mosquito-borne infection with symptoms similar to dengue and Zika—could finally be on the horizon. This is a key step toward addressing the emerging global health threat caused by climate change.? Read here.